/Companies

Ebamed

5 known investors

Find your way into Ebamed

Sign up to see every warm intro you have to Ebamed

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Ebamed team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software. It serves the cardiology and electrophysiology field, targeting patient treatment backed by clinical evidence.

Founders & leadership

GLGiovanni Leo
Giovanni LeoCo-Founder
DPDouglas Packer
Douglas PackerCo-Founder & Key Advisor
UAUgo Amaldi
Ugo AmaldiCo-Founder & Key Advisor
MIMarina Izzo
Marina IzzoChief Executive Officer & Director
AGAdriano Garonna
Adriano GaronnaChief Technology OfficerAdriano Garonna is Chief Technology Officer of EBAMed, which develops non-invasive cardiac ablation technology using particle and proton beam therapy to treat cardiac arrhythmias.
OCOlivier Coquoz
Olivier CoquozHead of R&D
MG
Marcin GołębickiChief Executive Officer

Investors · 5

Frequently asked questions

What does Ebamed do?
EBAMed develops non-invasive cardiac ablation technology using particle/proton beam therapy to treat cardiac arrhythmias, with in-house R&D focused on medical devices and cardiac software. It serves the cardiology and electrophysiology field, targeting patient treatment backed by clinical evidence.
Who founded Ebamed?
Ebamed was founded by Giovanni Leo, Douglas Packer, Ugo Amaldi.
Who are Ebamed's investors?
Ebamed's investors include CDP Venture Capital, Elysia Capital, LIFTT, OCCIDENT, Panakes Partners.